Summary
Chronic treatment with conventional lithium carbonate was interrupted in a selected group of 40 psychiatric patients of mixed sex and race. All patients had normal renal function. Serum samples were taken 12, 24, 36 and 48 h after the last dose and lithium was assayed by atomic absorption spectrophotometry. Decay rates calculated for the 12–24 h and 36–48 h periods yielded different values. This was ascribed to the presence of an incomplete redistribution phase during the earlier period. The distribution of elimination rates determined during the later period gave a more symmetrical spread and approximated a normal distribution. The mode, median, mean and standard deviation of the lithium elimination half-lives were 12.5, 14, 18.2 and 7.3 h and 22.5, 24.5, 29.8 and 10.1 h for the two periods, respectively. The results contrast sharply with another report of the distribution spread of elimination half-lives in a much larger sample. The current values have implications for dosage prediction, serum level monitoring and dosage formulation, especially sustained-release preparations. The evidence was against the possibility that some individuals ‘retain’ lithium.
Similar content being viewed by others
References
Almy GL, Taylor MA (1973) Lithium retention in mania. Arch Gen Psychiatry 29: 232
Altamura AE, Gouneni R, Sacchetti E, Smeraldi E (1977) Plasma and intracellular kinetics of Lithium after oral administration of various Lithium salts. Eur J Clin Pharmacol 12: 59–63
Amdisen A (1973) Serum Lithium estimations. Br Med J 1: 240
Amdisen A (1977) Serum level monitoring and clinical pharmacokinetics of Lithium. Clin Pharmacokinet 2: 73–92
Amdisen A (1978) Clinical and serum level monitoring in Lithium therapy and Lithium intoxication. J Anal Toxicol 2: 193–202
Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R (1972) Diagnostic cirteria for use in psychiatric research. Arch Gen Psychiatry 26: 57–63
Gibaldi M, Weintraub H (1971) Some considerations as to the determination and significance of biological half-life. J Pharm Sci 60: 624–626
Groth U, Prellwitz W, Jähnchen E (1974) Estimation of pharmacokinetic parameters of lithium from saliva and urine. Clin Pharmacol Ther 16: 490
Little BR, Platman SR, Fieve RR (1968) The measurement of Lithium in biological samples by atomic absorption spectrophotometry. Clin Chem NY 14: 1211–1217
Mason RW, McQueen EG, Keary PJ, James NM (1978) Pharmacokinetics of Lithium: elimination half-time, renal clearance and apparent volume of distribution in schizophrenia. Clin Pharmacokinet 3: 341–246
Serry M (1969) Lithium retention and response. Lancet: 1267–1268
Serry M, Andrews S (1969) The Lithium excretion test. Practical and biochemical aspects. Aust NZ J Psychiat 3: 395–397
Serry M (1969) The Lithium excretion test. Clinical application and interpretation. Aust NZ J Psychiatry 3: 390–394
Siegel S (1956) Non-Parametric statistics. McGraw Hill New York pp 120–121
Spiegel MR (1961) Theory and problems of statistics. McGraw Hill, New York, Chap. 5
Thornhill DP (1978) Pharmacokinetics of ordinary and sustained release Lithium carbonate in manic patients after acute dosage. Eur J Clin Pharmacol 14: 267–271
Wagner J (1963) Some possible errors in the plotting and interpretation of semilogarithmic plots of blood level and urinary excretion data. J Pharm Sci 52: 1097–1101
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thornhill, D.P., Field, S.P. Distribution of lithium elimination rates in a selected population of psychiatric patients. Eur J Clin Pharmacol 21, 351–354 (1982). https://doi.org/10.1007/BF00637625
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00637625